These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 4464051)

  • 1. Problems associated with the screening of drugs for possible teratogenic activity.
    Palmer AK
    Exp Embryol Teratol; 1974; 1(0):16-33. PubMed ID: 4464051
    [No Abstract]   [Full Text] [Related]  

  • 2. Sporadic malformations in laboratory animals and their influence on drug testing.
    Palmer AK
    Adv Exp Med Biol; 1972; 27():45-60. PubMed ID: 4680139
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of developmental toxicology of aspirin (acetylsalicylic acid) in rats using selected dosing paradigms.
    Gupta U; Cook JC; Tassinari MS; Hurtt ME
    Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):27-37. PubMed ID: 12852481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental and reproductive toxicity studies on artemisone.
    Schmuck G; Klaus AM; Krötlinger F; Langewische FW
    Birth Defects Res B Dev Reprod Toxicol; 2009 Apr; 86(2):131-43. PubMed ID: 19306395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The teratogenic activity of a thalidomide analogue, EM 12 in rabbits, rats, and monkeys.
    Schumacher HJ; Terapane J; Jordan RL; Wilson JG
    Teratology; 1972 Apr; 5(2):233-40. PubMed ID: 4623448
    [No Abstract]   [Full Text] [Related]  

  • 6. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists.
    Crofts F; Rohatagi S; Pino M; DeLise B; Zhang J; Nguyen M; Guittin P; Barbellion S; Brunel P; Hofmann T; Schmidt J; Wong M; Lockey P; Lerman S; Clark R
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Congenital deformities induced by drugs].
    Pagnini G; Paino G; Pelagalli GV
    Boll Soc Ital Biol Sper; 1978 Mar; 54(6):547-53. PubMed ID: 743471
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits.
    Cook JC; Jacobson CF; Gao F; Tassinari MS; Hurtt ME; DeSesso JM
    Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):5-26. PubMed ID: 12852480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Species differences in the metabolism of drugs].
    Sjöqvist F
    Nord Med; 1967 Oct; 78(42):1364. PubMed ID: 5590749
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimentally induced cardiovascular malformations in the chick embryo. Part II. Teratogenic effect of Tedral (theophylline, ephedrine, and phenobarbital) on cardiac development in chick embryos.
    Matsuoka R; Gilbert EF; Bruyere HJ; Fang TT; Nishikawa T; Opitz JM
    Birth Defects Orig Artic Ser; 1987; 23(1):449-52. PubMed ID: 3580559
    [No Abstract]   [Full Text] [Related]  

  • 11. [Embryotoxic properties of drugs].
    Smol'nikova NM; Golovanova IV; Proĭnova VA; Skosyreva AM; Strekalova SN
    Farmakol Toksikol; 1982; 45(4):115-9. PubMed ID: 6751867
    [No Abstract]   [Full Text] [Related]  

  • 12. Teratogenic drug screening. Present procedures and requirements.
    Tuchmann-Duplessis H
    Teratology; 1972 Jun; 5(3):271-85. PubMed ID: 5067718
    [No Abstract]   [Full Text] [Related]  

  • 13. Estimating variance functions in developmental toxicity studies.
    Bowman D; Chen JJ; George EO
    Biometrics; 1995 Dec; 51(4):1523-8. PubMed ID: 8589237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the developmental toxicity of aspirin in rabbits when administered throughout organogenesis or during sensitive windows of development.
    Cappon GD; Gupta U; Cook JC; Tassinari MS; Hurtt ME
    Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):38-46. PubMed ID: 12852482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Teratology and epidemiology in the study of environmental teratogens].
    Cayré R; Sánchez-Gómez C; Moreno-Rodríguez RA; de la Cruz MV
    Bol Med Hosp Infant Mex; 1992 Jul; 49(7):397-403. PubMed ID: 1418645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teratogenic potential of dichlorvos given by inhalation and gavage to mice and rabbits.
    Schwetz BA; Ioset HD; Leong BK; Staples RE
    Teratology; 1979 Dec; 20(3):383-7. PubMed ID: 542893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of mammalian models in teratology.
    Palmer AK
    Prog Clin Biol Res; 1985; 163A():97-106. PubMed ID: 3969396
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanism of teratogenic action of thalidomide.
    Vaisman B
    Teratology; 1996 May; 53(5):283-4. PubMed ID: 8879085
    [No Abstract]   [Full Text] [Related]  

  • 19. [Principles and concepts of teratogenesis. I. The teratogenic injury (author's transl)].
    Rooze M
    Rev Med Brux; 1980 Oct; 1(8):523-33. PubMed ID: 6781025
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of teratogenic potential of therapeutic agents: preclinical toxicology.
    Frederick GL
    Clin Invest Med; 1985; 8(4):323-7. PubMed ID: 4075617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.